Literature DB >> 10467837

Intraventricular haemorrhage and its prognosis, prevention and treatment in term infants.

C Mao1, J Guo, B M Chituwo.   

Abstract

The purpose of this study was to investigate the prognosis of intraventricular haemorrhage (IVH) in term infants and its prevention and treatment. The authors diagnosed IVH in full-term newborns by using computerized tomography (CT) or cranial ultrasonography (US). The results of CT or US were reviewed and the grade of haemorrhage was determined by an independent radiologist using Papile's criteria. All the infants were examined on the first day of their life by a paediatrician and judged to be full term. Survivors were examined between age 2 and 10 years at the Child Development Clinic by a Developmental Paediatrician using the Gesell scales and a standard neurologic examination. The results showed that three of 36 infants (8 per cent) died; complications of pregnancy were present in 17 mothers (47 per cent); nine women tested negative for platelet antigen 1 and their infants exhibited alloimmune thrombocytopenia. Age at diagnosis ranged from in utero to 28 days. Clinical presentation included feeding intolerance, irritability, jaundice, fever, and restlessness. Of the nine children with grade IV IVH, three died and six survivors were severely handicapped. Overall, 22 (67 per cent) of 33 survivors had no or mild handicap. The results of this study suggest that severity of haemorrhage was of prognostic value. Perinatal alloimmune thrombocytopenia turned out to be the single most important cause of severe haemorrhage and poor outcome. Identification and treatment of these infants must begin in utero if we are to prevent IVH and its complications in this group of patients.

Entities:  

Mesh:

Year:  1999        PMID: 10467837     DOI: 10.1093/tropej/45.4.237

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  7 in total

1.  Workshop on evaluation of pediatric long-term neurocognitive development and medical products.

Authors:  Ann W McMahon; Leonard P Kapcala; Philip H Sheridan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-09-19       Impact factor: 2.890

2.  Fetal and Neonatal Alloimmune Thrombocytopenia: Management and Outcome of a Large International Retrospective Cohort.

Authors:  Marije M Kamphuis; Heidi Tiller; E S van den Akker; Magnus Westgren; Eleonor Tiblad; Dick Oepkes
Journal:  Fetal Diagn Ther       Date:  2016-10-12       Impact factor: 2.587

3.  Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy.

Authors:  Julie A Peterson; Adam Kanack; Dhirendra Nayak; Daniel W Bougie; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal:  Transfusion       Date:  2012-09-25       Impact factor: 3.157

Review 4.  Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Authors:  Heidi Tiller; Anne Husebekk; Maria Therese Ahlen; Tor B Stuge; Bjørn Skogen
Journal:  Int J Womens Health       Date:  2017-04-19

5.  Body representation difficulties in children and adolescents with autism may be due to delayed development of visuo-tactile temporal binding.

Authors:  Danielle Ropar; Katie Greenfield; Alastair D Smith; Mark Carey; Roger Newport
Journal:  Dev Cogn Neurosci       Date:  2017-04-27       Impact factor: 6.464

6.  Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry.

Authors:  Heidi Tiller; Marije M Kamphuis; Olof Flodmark; Nikos Papadogiannakis; Anna L David; Susanna Sainio; Sinikka Koskinen; Kaija Javela; Agneta Taune Wikman; Riitta Kekomaki; Humphrey H H Kanhai; Dick Oepkes; Anne Husebekk; Magnus Westgren
Journal:  BMJ Open       Date:  2013-03-22       Impact factor: 2.692

7.  Visuo-tactile integration in autism: atypical temporal binding may underlie greater reliance on proprioceptive information.

Authors:  Katie Greenfield; Danielle Ropar; Alastair D Smith; Mark Carey; Roger Newport
Journal:  Mol Autism       Date:  2015-09-14       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.